|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization expense | ||
| Stock-based compensation expense | ||
| Non-cash lease expense | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other current assets | ||
| Other assets | ||
| Accounts payable | ||
| Accrued expenses and other current liabilities | ||
| Other long term liabilities | ||
| Deferred rent | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities: | ||
| Purchases of property and equipment | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from issuance of preferred stock , net of issuance costs | ||
| Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts, commissions and offering costs of $13,022 | ||
| Proceeds from issuance of common stock under ESPP | ||
| Proceeds from exercise of stock options | ||
| Net cash provided by financing activities | ||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | ||
| Cash, cash equivalents and restricted cash at beginning of period | ||
| Cash, cash equivalents and restricted cash at end of period | ||
| Supplemental disclosure of cash flows | ||
| Property and equipment purchases in accounts payable | ||
| Supplemental disclosure of noncash financing activities | ||
| Vesting of early exercised options | ||
| Conversion of preferred stock to common stock upon initial public offering | ||
| Reconciliation of cash, cash equivalents and restricted cash | ||
| Cash and cash equivalents | ||
| Restricted cash (included in other assets) |
Loading...
